Michael Dastoor
Analyst · Bank of America Merrill Lynch. Please go ahead
Thank you, Mark, and good afternoon, everyone. Q1 was an excellent quarter in many ways. We saw good diversification and strong performances by both segments. Net revenue for the first quarter was $6.5 billion, an increase of 16% year-over-year, led by strength in both segments. GAAP operating income was $217 million and our GAAP diluted earnings per share was $0.76. Core operating income during the quarter was $254 million, an increase of 12% year-over-year, representing a core operating margin of 3.9%. Net interest expense during the quarter was $53 million, ahead of expectations, driven mainly by higher levels of intra-quarter borrowing to fund opportunistic share repurchases. As a result, we repurchased nearly 8 million shares during the quarter. As we move towards the end of the year, we expect our interest expense to moderate, as the U.S. Tax Act, which we highlighted in September, will allow us to more effectively return cash to the United States. Our core tax rate for the quarter was 27%. Core diluted earnings per share was $0.90, a 13% improvement over the prior year quarter. There were two items, which impacted our GAAP results during the quarter. First, we recorded an income tax benefit of $13 million associated with the U.S. Tax Act, mainly related to the one-time transition tax to adjust amounts recorded in FY 2018. Second, as expected, we recorded approximately $9 million of acquisition and integration-related expenses associated with our strategic collaboration with Johnson & Johnson Medical Devices companies. Now turning to our first quarter segment results. Revenue for our DMS segment was $3 billion, an increase of 10% on a year-over-year basis. Core margins for the segment improved 40 basis points year-over-year to 5.6%. Despite a weaker than expected mobility market, our DMS segment performed very well, driven by strength in several key end markets, including healthcare, edge devices and accessories and lifestyle. DMS represented 46% of total company revenue in the quarter. Revenue for our EMS segment increased by 22% year-over-year to $3.5 billion. As Mark indicated during the quarter, our teams did a good job ramping new wins, which contributed to a strong year-over-year sales growth. From an end market perspective, print and retail, Industrial & Energy and 5G and cloud, all performed well in the quarter, offset by weakness in capital equipment. Core margins for the segment declined 60 basis points year-over-year to 2.4%, driven mainly by two factors. First, softness in the capital equipment space; and second, the costs associated with ramping new business awards. DMS represented 54% of total company revenue in the quarter. Turning now to the balance sheet. As a reminder in Q1, we adopted the new accounting standard ASU 2016-15. The new standard impacts the classification of certain cash receipts associated with the deferred purchase price note receivables on our asset-backed securitization programs. As I highlighted on our previous call, the effects of this change have been applied retrospectively and are not the result of any fundamental change in our underlying business. Adjusting for the new standard, adjusted cash flows provided by operations was $5 million in Q1, compared to a usage of $54 million in the prior year quarter. As we implemented the new standard during the quarter, we amended our existing securitization programs to better optimize their efficiency. As a result, you will note higher accounts receivables. Our working capital fundamentals, however, remained unchanged. When adjusting the prior quarter for this optimization of our programs, we estimate sales days increased approximately one day sequentially on a like-for-like basis. Net capital expenditure for the first quarter was $221 million, and for the full fiscal year are still expected to be $800 million. Core return on invested capital for Q1 was 23.1%, an increase of 210 basis points on a year-over-year basis. We exited the quarter with total debt-to-EBITDA levels of approximately two times and cash balances of $804 million. Turning now to our capital return framework. As previously mentioned, during Q1, we repurchased approximately 8 million shares for $205 million. For the year, we intend to fully utilize the current repurchase authorization of $350 million, as we remain committed to returning capital to shareholders. Since the inception of our capital return framework in June of 2016, we have repurchased 41 million shares, bringing our total returns to shareholders, including repurchases and dividends to approximately $1.2 billion. Turning now to our second quarter guidance. DMS segment revenue is expected to increase 6% on a year-over-year basis to $2.6 billion, while the EMS segment revenue is expected to increase 23% on a year-over-year basis to $3.5 billion. We expect total company revenue in the second quarter of fiscal 2019 to be in the range of $5.8 billion to $6.4 billion for an increase of 15% at the midpoint of the range. Core operating income is estimated to be in the range of $165 million to $205 million, with core operating margin in the range of 2.8% to 3.2%. Core diluted earnings per share is estimated to be in the range of $0.51 to $0.71. GAAP diluted earnings per share is expected to be in the range of $0.20 to $0.48. The tax rate on core earnings in the second quarter is estimated to be 27%. In closing, I’m quite pleased with the momentum underway within our business in terms of both diversification and new business awards. We remain focused on delivering $3 in core EPS on $25 billion in revenue, with adjusted free cash flows in the range of $350 million for the year. Over the longer-term, we remain focused on delivering shareholder value through strong margins, free cash flow and earnings growth. I’ll now turn the call over to Adam to begin Q&A.